Adaptin Bio (APTN) Other Non Operating Income (2024 - 2026)
Adaptin Bio's (APTN) quarterly Other Non Operating Income came in at $326345.0 in Q1 2026, little changed year-over-year from $326345.0 in Q1 2025, and little changed quarter-over-quarter from $326345.0 in Q1 2025.
Analysis
Adaptin Bio (APTN) Other Non Operating Income (2024 - 2026) Analysis & Trends
Adaptin Bio has disclosed Other Non Operating Income across 3 years of filings, most recently posting $326345.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income changed 0.0% year-over-year to $326345.0; the TTM figure through Jun 2026 stood at $326345.0 (up 142.97% YoY), while the FY2025 annual figure was $326345.0, up 267.75% from the prior year.
- Other Non Operating Income came in at $326345.0 for Q1 2026 at Adaptin Bio, roughly flat from $326345.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $326345.0 in Q1 2025 to a low of -$185782.0 in Q4 2024.
- Average Other Non Operating Income over 3 years is $76358.8, with a median of -$1253.0 recorded in 2024.
- Year-over-year, Other Non Operating Income soared 245472.18% in 2025 and changed 0.0% in 2026.
- Over 3 years, Other Non Operating Income stood at -$185782.0 in 2024, then soared by 275.66% to $326345.0 in 2025, then changed by 0.0% to $326345.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $326345.0 in Q1 2026, $326345.0 in Q1 2025, and -$185782.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Adaptin Bio | 56.76 Mn | 56.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 326,345.00 |
| Mar 31, 2025 | 326,345.00 |
| Dec 31, 2024 | -185,782.00 |
| Sep 30, 2024 | -6,249.00 |
| Jun 30, 2024 | -2,373.00 |
| Mar 31, 2024 | -133.00 |